According to the most recent statistics from the Nigeria Centre for Disease Control (NCDC), monkeypox and Lassa fever cases in the nation increased over the past week.
According to the NCDC’s Update on Monkeypox (MPX) in Nigeria, which was released yesterday, “100 new suspected cases were reported in Epi week 34, 2022 (August 22 to 28, 2022) from 21 states: Lagos (17), Abia (16), Imo (14), Delta (seven), Ondo (seven), Bayelsa (five), Gombe (five), Rivers (four), Benue (three), Ebonyi (three), Edo (three), Plate (one).
Out of the 100 suspected cases, 36 additional confirmed cases from 14 states—Lagos (seven), Abia (six), Bayelsa (five), Edo (three), Ondo (three), Delta (two), Ebonyi (two), Rivers (two), Anambra (one), Benue (one), Gombe (one), Imo (one), Katsina (one), and Oyo (one)—have been reported in Epi Week 34.
The NCDC reports that Nigeria documented 704 suspected cases between January 1 and August 28, 2022, with 277 confirmed cases (186 men and 91 women) from 30 states: Lagos (49), Ondo (22), Bayelsa (19), Rivers (18), Edo (16), Adamawa (15), Abia (15), Delta (14), FCT (11), Imo (11), Anambra (10), Nasarawa (9), Ogun (7), Plateau (6), Taraba (5), Kwara (5), Kano (5), Gombe (5), Ebonyi (5), Oyo (5), Katsina (5), Cross River (4), Benue (4), Borno (3), Ko (one).
It observed that six states—Delta (one), Lagos (one), Ondo (one), Akwa Ibom (one), Kogi (one), and Taraba—recorded six connected deaths in 2022. (one).
Additionally, the NCDC announced that there were 10 additional confirmed cases of Lassa fever, up from 5 in week 34 of 2022. These were reported in the states of Ondo, Edo, and Nasarawa.
According to the NCDC, 170 deaths have been reported overall from Week 1 to Week 35 of 2022, with a Case Fatality Rate (CFR) of 18.7%, which is lower than CFR for the same period in 2021. (22.7 per cent).
“Overall for 2022, 101 Local Councils in 25 states have reported at least one confirmed case.
Over the weekend, the FIF Governing Board formally launched the fund during its first meeting.
The fund will provide a dedicated stream of additional, long-term financing to boost PPR capabilities in low- and middle-income countries and close critical gaps through investments and technical support at the national, regional, and global levels, according to a statement released yesterday by the WHO.
The fund will make use of the assets and comparative advantages of significant PPR-related institutions, offer complementary assistance, enhance partner coordination, encourage increased national investments, provide a platform for advocacy, and assist in concentrating and maintaining much-needed, high-level attention on improving health systems.
In November 2022, the first requests for investment projects that will be sponsored by the FIF will go live.
David Malpass, President of the World Bank Group, stated: “COVID-19 has emphasized the urgent need for action to strengthen health systems. Spending money now will save resources and lives for years to come. We are happy to have been able to move quickly to establish the fund and appreciate the broad support from the international community for this new, multilateral financial intermediary fund at the World Bank to assist low- and middle-income countries and regions in better preparing for global health crises.
Follow our socials Whatsapp, Facebook, Instagram, Twitter, and Google News.
